MENU

SWTX Stock Tickeron detected bullish Stock Pattern: Three Rising Valleys SWTX on February 10, 2025, netting in a 45.91% gain over 4 weeks

A.I.dvisor
at Tickeron.com
Loading...
+45.91% Gain from a Successful pattern Three Rising Valleys
SWTX - SpringWorks Therapeutics
Tickeron
Ticker: SWTX
Company: SpringWorks Therapeutics
Gain: +45.91%
Confirmed: 02/10/25
Succeeded: 02/10/25
Total length: 28 days
On January 13, 2025, A.I.dvisor detected a Three Rising Valleys Pattern (Bullish) for SpringWorks Therapeutics (SWTX, $37.01). On February 10, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $51.22. On February 10, 2025, SWTX reached the target price resulting in a +4 for traders who took a long position in the stock.

Aroon Indicator for SWTX shows an upward move is likely

SWTX's Aroon Indicator triggered a bullish signal on February 21, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 222 similar instances where the Aroon Indicator showed a similar pattern. In of the 222 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 29, 2025. You may want to consider a long position or call options on SWTX as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SWTX just turned positive on January 30, 2025. Looking at past instances where SWTX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

SWTX moved above its 50-day moving average on February 04, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SWTX crossed bullishly above the 50-day moving average on February 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for SWTX moved above the 200-day moving average on January 27, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where SWTX advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SWTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SWTX broke above its upper Bollinger Band on February 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SWTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.074) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.012). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.602). SWTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (22.523) is also within normal values, averaging (250.738).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SWTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Washington Boulevard
Phone
+1 203 883-9490
Employees
305
Web
https://www.springworkstx.com